AGENDA AT A GLANCE
8:50
IMAPAC’s Opening Address
8:55
Chairman’s Opening Address
Leadership Panel:
Indian Biologics Market: Trends & Future
9:00
Leadership Panel: India for the World: Biologics Potential and Global Strategy
- India’s competitive edge in biosimilars and large-scale manufacturing
- Strategic collaborations with global pharma for co-development
- Fostering a value-based ecosystem through affordable therapies, patient access, and clinical outcomes
- Future trajectory in the next 5 years
Panelists:
9:50
Reserved for Service/Solution Provider
Keynote Address:
India’s Strengths for Affordable Therapies
10:05
India’s Strategic Advantage in Delivering Affordable Biologics and Advanced Therapies (TBC)
- Leveraging India's cost-effective R&D and manufacturing ecosystem
- Public-private partnerships driving access and innovation in biologics
- India's global role in supplying affordable therapies to emerging and developed markets
10:30
Morning Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Advancing from Research & Formulation to Clinical Trials
11:50
Clinical Advances in Regenerative Medicine
- Current Landscape: Overview of the latest developments and clinical advancements in regenerative medicine.
- Key Challenges: Addressing scientific, regulatory, and translational hurdles in clinical development.
- Transforming Horizons: Innovative strategies to maximize therapeutic potential and accelerate progress.
12:15
Lunch Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Regulatory and Advances in Upstream & Downstream Processing
2:25
Reserved for Service/Solution Provider
3:15
Afternoon Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Manufacturing & Quality Assurance
4:00
Harnessing Exosomes for Drug Delivery and Cell Therapy: Bridging Discovery, Development, and Deployment
- Exosomes stability, targeting ability, and biocompatibility make them ideal for drug delivery.
- How exosomes enhance drug delivery for small molecules, RNA, and gene-editing tools.
- The role of exosomes as cell-free alternatives to stem, dendritic, and NK cell therapies.
- Translational progress toward scalable, GMP-ready exosome platforms for clinical use.
4:25
Reserved for Service/Solution Provider
5:15
Chairman’s Closing Remarks
5:20
End of Conference Day 1
6:00
Biopharma Excellence Awards 2026
8:50
IMAPAC’s Opening Address
8:55
Chairman’s Opening Address
Keynote Address: Next-Generation Therapies in India
Manufacturing Automation & Process Scale-up
9:50
Scaling Up Biologics Manufacturing: From Lab to Commercial Scale
- Key considerations in scaling unit operations (bioreactors, filtration, chromatography)
- Maintaining process consistency and product quality during scale-up
- Tech transfer strategies between R&D and manufacturing sites
10:15
Morning Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Advancements in Cell & Gene Therapy
11:00
Utilizing Induced Pluripotent Stem Cells (iPSCs) for Advanced 3D Screening Model and Therapeutic Advancements
- Development of 3D organoid and tissue models using iPSCs for drug screening
- Applications in disease modeling, target validation, and toxicity testing
- Challenges and future directions in integrating iPSCs into biologics pipelines
12:15
Lunch Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Operational Excellence & Supply Chain Solutions
2:00
Driving Operational Excellence in Biologics Manufacturing: Lean, Agile, and Digital
- Implementing lean methodologies to reduce waste and improve efficiency
- Agile manufacturing practices for rapid tech transfer and change management
- Leveraging digital tools for real-time performance monitoring and optimization
2:25
Reserved for Service/Solution Provider
3:15
Afternoon Tea Break, Exhibition Viewing, Poster Presentations & 1-1 Attendee Networking
Regulatory Updates and CGT Advancements
4:25
Reserved for Service/Solution Provider
4:50
Tackling Toxicity in ADC Development: From Design to Patient Safety
- Understanding off-target and bystander effects: mechanisms and mitigation strategies
- Innovations in linker stability and payload selection to reduce systemic toxicity
- Clinical trial insights on managing adverse events and improving therapeutic index
Closing Panel: Forging India's Vaccine & Biologics Future
5:15
Leadership Panel: Shaping the Future of Novel Vaccines & Biologics – Innovations, Strategies, and Global Collaboration
- Explore recent innovations and technologies transforming the vaccines and biologics industry
- Discuss strategies for advancing affordable biologics and vaccines, especially in the Global South
- Identify opportunities for international collaboration to enhance vaccine and biologics development
- Address clinical trial challenges in developing countries for novel vaccines and biologics
Moderator:
Panelists:
5:55
Chairman’s Closing Remarks
6:00
End of Conference
For Speaking Opportunities, Kindly Contact:
